Variants of RhD - current testing and clinical consequences

British Journal of Haematology

Volumn 161, Issue 4, 2013, Pages 461-470

  Daniels, Geoff ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

D antigen; D variant; Partial D; Rh blood group system; Weak D

Indexed keywords

EPITOPE; MESSENGER RNA; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; BLOOD DONOR; BLOOD GROUP RH; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; GENE INACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MOLECULAR TYPING; PHENOTYPE; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RHESUS D GENE; RISK REDUCTION; SICKLE CELL ANEMIA;

FEMALE; GENETIC VARIATION; HUMANS; MALE; POLYMORPHISM, GENETIC; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM;

EID: 84876794954     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12275     Document Type: Review

References (87)

1. AABB. (2011) Standards for Blood Banks and Transfusion Services, 27th edn.AABB, Bethesda, MD.
2. Agre, P.C., Davies, D.M., Issitt, P.D., Lamy, B.M., Schmidt, P.J., Treacy, M. & Vengelen-Tyler, V. (1992) A proposal to standardize terminology for weak D antigen. Transfusion, 32, 86-87.
3. Avent, N.D. (2007) New insight into the Rh system: structure and function. ISBT Science Series, 2, 35-43.
4. Avent, N.D., Ridgwell, K., Tanner, M.J.A. & Anstee, D.J. (1990) cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochemical Journal, 271, 821-825.
5. VIccEe phenotypes. Blood, 89, 1779-1786.
6. Avent, N.D., Martinez, A., Flegel, W.A., Olsson, M.L., Scott, M.L., Nogués, N., Písǎcka, M., Daniels, G., van der Schoot, E., Muñiz-Diaz, E., Madgett, T.E., Storry, J.R., Beiboer, S.H., Maaskant-van Wijk, P.A., von Zabern, I., Jiménez, E., Tejedor, D., López, M., Camacho, E., Cheroutre, G., Hacker, A., Jinoch, P., Svobodova, I. & de Haas, M. (2007) The BloodGen project: towards mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion, 47(1S), 40S-46S.
7. Beckers, E.A.M., Faas, B.H.W., Ligthart, P., Simsek, S., Overbeeke, M.A., von dem Borne, A.E., van Rhenen, D.J. & van der Schoot, C.E. (1996) Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion, 36, 567-574.
8. Beckers, E.A.M., Ligthart, P.C., Overbeeke, M.A.M., Maaskant, P.A. & van Rhenen, D.J. (2004) A patient with weak D type 1 and anti-D: auto or allo? Vox Sanguinis, 87(Suppl. 3), 75 (abstract).
9. Castilho, L., Rios, M., Rodrigues, A., Pellegrino, J., Saad, S.T.O. & Costa, F.F. (2005) High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD. Transfusion Medicine, 15, 49-55.
10. el red blood cells in Taiwan: two case reports. Transfusion, 46(Suppl.), 129A.
11. Chérif-Zahar, B., Bloy, C., Le Van Kim, C., Blanchard, D., Bailly, P., Hermand, P., Salmon, C., Cartron, J.P. & Colin, Y. (1990) Molecular cloning and protein structure of a human blood group Rh polypeptide. Proceedings of the National Academy of Science USA, 87, 6243-6247.
12. Clausen, F.B., Christiansen, M., Steffensen, R., Jørgensen, S., Nielsen, C., Jakobsen, M.A., Madsen, R.D., Jensen, K., Krog, G.R., Rieneck, K., Sprogøe, U., Homburg, K.M., Grunnet, N. & Dziegiel, M.H. (2012) Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenantal RhD prophylaxis. Transfusion, 52, 752-758.
13. Colin, Y., Chérif-Zahar, B., Le Van Kim, C., Raynal, V., Van Huffel, V. & Cartron, J.-P. (1991) Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood, 78, 2747-2752.
14. Conroy, M.J., Bullough, P.A., Merrick, M. & Avent, N.D. (2005) Modelling the human rhesus proteins: implications for structure and function. British Journal of Haematology, 131, 543-551.
15. Daniels, G. (2013) Human Blood Groups, 3rd edn. Wiley, Oxford.
16. Daniels, G.L., Faas, B.H.W., Green, C.A., Smart, E., Maaskant-van Wijk, P.A., Avent, N.D., Zondervan, H.A., von dem Borne, A.E. & van der Schoot, C.E. (1998) The Rh VS and V blood group polymorphisms in Africans: a serological and molecular analysis. Transfusion, 38, 951-958.
17. Daniels, G., Poole, G. & Poole, J. (2007) Partial D and weak D: can they be distinguished? Transfusion Medicine, 17, 145-146.
18. Daniels, G., Finning, K., Martin, P. & Massey, E. (2009) Non-invasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenatal Diagnosis, 29, 101-107.
19. Daniels, G., Finning, K., Wade, A., Massey, E., Soothill, P., Phillips, C.J., Martin, W.L. & Chitty, L.S. (2012) Implementation of fetal RHD typing in all RHD-negative women: timing, costs, and efficiency. Vox Sanguinis, 103(Suppl.1), 34 (abstract).
20. Dogic, V., Bingulac-Popovic, J., Babic, I., Hundric-Haspl, Z., Jurakovic-Loncar, N., Mratinovic-Mikulandra, J., Vuk, T., Balija, M. & Jukic, I. (2011) Distribution of weak D types in Croatian population. Transfusion Medicine, 21, 278-279.
21. Engelfriet, C.P., Reesink, H.W. eds (2006) International forum. Testing for weak D. Vox Sanguinis, 90, 140-153.
22. Esteban, R., Montero, R., Flegel, W.A., Wagner, F.F., Subirana, L., Parra, R., Ribera, A. & Nogués, N. (2006) The D category VI type 4 allele is prevalent in the Spanish population. Transfusion, 46, 616-623.
23. Faas, B.H.W., Beckers, E.A.M., Wildoer, P., Ligthart, P.C., Overbeeke, M.A., Zondervan, H.A., von dem Borne, A.E. & van der Schoot, C.E. (1997) Molecular background of VS and weak C expression in blacks. Transfusion, 37, 38-44.
24. Finning, K., Martin, P., Summers, J., Massey, E., Poole, G. & Daniels, G. (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. British Medical Journal, 336, 816-818.
25. Flegel, W.A. (2011) Molecular genetics and clinical applications for RH. Transfusion & Apheresis Science, 44, 81-91.
26. Flegel, W.A., Khull, S.R. & Wagner, F.F. (2000) Primary anti-D immunization by weak D type 2 RBCs. Transfusion, 40, 428-434.
27. Flegel, W.A., Denomme, G.A. & Yazer, M.H. (2007) On the complexity of D antigen typing: a handy decision tree in the age of molecular blood group genetics. Journal of Obstetrics & Gynaecology Canada, 29, 746-752.
28. Flegel, W.A., von Zabern, I. & Wagner, F.E. (2009) Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion, 49, 465-471.
29. Frohn, C., Dümbgen, L., Brand, J.-M., Görg, S., Luhm, J. & Kirchner, H. (2003) Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion, 43, 893-898.
30. Gardener, G.J., Legler, T.J., Hyett, J.A., Liew, Y.-W., Flower, R.L. & Hyland, C.A. (2012) Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion, 52, 2016-0027.
31. Gassner, C., Doescher, A., Drnovsek, T.D., Rozman, P., Eicher, N.I., Legler, T.J., Lukin, S., Garritsen, H., Kleinrath, T., Egger, B., Ehling, R., Körmöczi, G.F., Kilga-Nogler, S., Schoenitzer, D. & Petershofen, E.K. (2005) Presence of RHD in serologically D-, C/E+ individuals: a European mulitcenter study. Transfusion, 45, 527-538.
32. Gonzalez-Porras, J.R., Graciani, I.F., Perez-Simon, J.A., Martin-Sanchez, J., Encinas, C., Conde, M.P., Nieto, M.J. & Corral, M. (2008) Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion, 48, 1318-1324.
33. Gruswitz, F., Chaudhary, S., Ho, J.D., Schlessinger, A., Pezeshki, B., Ho, C.M., Sali, A., Westhoff, C.M. & Stroud, R.M. (2010) Function of human Rh based on structure of RhCG at 2.1 Å. Proceedings of the National Academy of Sciences USA, 107, 9638-9643.
34. de Haas, M., van der Ploeg, C.P.B., Scheffer, P.G., Verlinden, D.A., Hirschberg, H., Abbink, F. & van der Schoot, C.E. (2012) A nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D. ISBT Science Series, 7, 164-167.
35. Haer-Wigman, L., Veldhuisen, B., Jonkers, R., Lodén, M., Madgett, T.E., Avent, N.D., de Haas, M. & van der Schoot, C.E. (2013) RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion, doi: 10.1111/j.1537-2995.2012.03919.x. [Epub ahead of print].
36. Hemker, M.B., Ligthart, P.C., Berger, L., van Rhenen, D.J., van der Schoot, C.E. & Maaskant-van Wijk, P.A. (1999) DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood, 94, 4337-4342.
37. u-positive mother. Vox Sanguinis, 27, 92-94.
38. Va-like variant found in Japanese individuals. Vox Sanguinis, 78, 122-125.
39. Klein, H.K. & Anstee, D.J. (2005) Mollison's Blood Transfusion in Clinical Medicine, 11th edn. Blackwell Publishing, Oxford, UK.
40. Körmöczi, G.F., Gassner, C., Shao, C.-P., Uchikawa, M. & Legler, T.J. (2005) A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion, 45, 1561-1567.
41. Krog, G.R., Clausen, F.B., Berkowicz, A., Jørgensen, L., Rieneck, K., Nielsen, L.K. & Dziegiel, M.H. (2011) Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion, 51, 2278-2285.
42. u variant mother. Transfusion, 23, 91-94.
43. Liu, H.-C., Eng, H.-L., Yang, Y.-F., Wang, Y.H., Lin, K.T., Wu, H.L. & Lin, T.M. (2010) Aberrant RNA splicing in RHD 7-9 exons of DEL individuals in Taiwan: a mechanism study. Biochimica Biophysica Acta, 1800, 565-573.
44. B). Vox Sanguinis, 16, 231-232.
45. Lubenko, A., Contreras, M. & Habash, J. (1989) Should anti-Rh immunoglobulin be given to D variant women? British Journal of Haematology, 72, 429-433.
46. Va. British Journal of Haematology, 76, 537-539.
47. Milkins, C., Berryman, J., Cantwell, C., Elliott, C., Haggas, R., Jones, J., Rowley, M., Williams, M. & Win, N. (2013) Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 23, 3-35. Also see: www.bcshguidelines.com/4_HAEMATOLOGY_GUIDELINES.html.
48. Mota, M., Fonseca, N.L., Rodrigues, Á., Kutner, J.M. & Castilho, L. (2005) Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sanguinis, 88, 130-135.
49. VI category phenotype. Blood, 83, 1129-1135.
50. Müller, T.H., Wagner, F.F., Trockenbacher, A., Eicher, N.I., Flegel, W.A., Schönitzer, D., Schunter, F. & Gassner, C. (2001) PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion, 41, 45-52.
51. Needs, M., Poole, J., Tilley, L., Stern, S., Preddy, I. & Win, N. (2007) Stimulation of anti-D in pregnancy by a weak D type 3 foetus. Transfusion Medicine, 17(Suppl.1), 40 (abstract).
52. Noizat-Pirenne, F. & Tournamille, C. (2011) Relevance of RH variants in transfusion of sickle cell patients. Transfusion Clinique Biologique, 18, 527-535.
53. Noizat-Pirenne, F., Verdier, M., Lejealle, A., Mercadier, A., Bonin, P., Peltier-Pujol, F., Fialaire-Legendre, A., Tournamille, C., Bierling, P. & Ansart-Pirenne, H. (2007) Weak D phenotypes and transfusion safety: where do we stand in daily practice? Transfusion, 47, 1616-1620.
54. Okubo, Y., Seno, T., Yamano, H., Yamaguchi, H., Lomas, C. & Tippett, P. (1991) Partial D antigens disclosed by a monoclonal anti-D in Japanese blood donors. Transfusion, 31, 782.
55. Okuda, H., Suganuma, H., Kamesaki, T., Kumada, M., Tsudo, N., Omi, T., Iwamoto, S. & Kajii, E. (2000) The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE through complete sequencing. Biochemical Biophysical Research Communications, 274, 670-683.
56. Va phenotype. Biochemical Biophysical Research Communications, 254, 786-794.
57. Østgård, P., Fevang, F. & Kornstad, L. (1986) Anti-D in a 'D positive' mother giving rise to severe haemolytic disease of the newborn. Acta Paediatrica Scandinavica, 75, 175-178.
58. Pelc-Klopotowska, M., Guz, K., Walaszcyk, A., Orzinska, A. & Michalewska, B. (2010) Weak D type 2 patient with allo anti-D. Vox Sanguinis, 99(Suppl. 1), 367 (abstract).
59. B- phenotype in black persons. Transfusion, 49, 495-504.
60. Pham, B.-N., Roussel, M., Peyrard, T., Beolet, M., Jan-Lasserre, V., Gien, D., Ripaux, M., Bourgouin, S., Kappler-Gratias, S., Rouger, P. & Le Pennec, P.Y. (2011) Anti-D investigations in individuals expressing weak D type 1 or weak D type 2: allo- or autoantibodies? Transfusion, 51, 2679-2685.
61. Rodrigues, M.J., Rodrigues, F., Tilley, L., Poole, J., Chabert, T. & Sousa, G. (2006) Several new examples of weak D type 38 in the Portuguese population. Transfusion, 46(Suppl.), 141A-142A (abstract).
62. Rouillac, C., Colin, Y., Hughes-Jones, N.C., Beolet, M., D'Ambrosio, A.M., Cartron, J.P. & Le Van Kim, C. (1995) Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes. Blood, 85, 2937-2944.
63. Roxby, D., Coloma, M., Flegel, W.A., Poole, J., Martin, P. & Abbott, R. (2004) Observation of anti-D after D-positive transfusion in an individual with weak D type-1 phenotype. Vox Sanguinis, 87(Suppl. 3), 77-78.
64. Scott, M. (2002) Section 1A. Rh serology. Coordinators report. Transfusion Clinique Biologique, 9, 23-29.
65. Shao, C.-P. (2010) Transfusion of RhD-positive blood in "Asia type" DEL recipients. New England Journal of Medicine, 362, 472-473.
66. Shao, C.-P., Wen, X. & Zhou, Y.-Y. (2006) Multiple isoforms excluding normal RhD mRNA detected in Rh blood group Del phenotype with RHD 1227A allele. Transfusion and Apheresis Science, 34, 142-152.
67. Silvy, M., Di Cristofaro, J., Beley, S., Papa, K., Rits, M., Richard, P., Chiaroni, J. & Bailly, P. (2011) Identification of RHCE and KEL alleles in large cohorts of Afro-Caribbean and Comorian donors by multiplex SNaPshot and fragment assays: a transfusion support for sickle cell disease patients. British Journal of Haematology, 154, 260-270.
68. Singleton, B.K., Green, C.A., Avent, N.D., Martin, P.G., Smart, E., Daka, A., Narter-Olaga, E.G., Hawthorne, L.M. & Daniels, G. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in most Africans with the Rh D-negative blood group phenotype. Blood, 95, 12-18.
69. St-Louis, M., Richard, M., Côté, M., Éthier, C. & Long, A. (2011) Weak D type 42 cases found in individuals of European descent. Immunohematology, 27, 20-24.
70. Tippett, P. & Sanger, R. (1962) Observations on subdivisions of the Rh antigen D. Vox Sanguinis, 7, 9-13.
71. UK Blood Transfusion and Tissue Transplantation Services. (2005) Guidelines for the Blood Transfusion Service in the UK (7th edn.). www.transfusionguidelines.org.uk/index.aspx?Publication=RB. Chapter 13.
72. Vege, S., Fong, C., Lomas-Francis, C., Nickle, P., Horn, T., Delaney, M., Meny, G. & Westhoff, C.M. (2011) Weak D type 2 and production of anti-D. Transfusion, 51(Suppl. 3), 41A (abstract).
73. Wagner, F.F. & Flegel, W.A. (2000) RHD gene deletion occurred in the Rhesus box. Blood, 95, 3662-3668.
74. Wagner, F.F., Gassner, C., Müller, T.H., Schönitzer, D., Schunter, F. & Flegel, W.A. (1998) Three molecular structures cause Rhesus D category VI phenotypes with distinct immunohematologic features. Blood, 91, 2157-2168.
75. Wagner, F.F., Gassner, C., Müller, T.H., Schönitzer, D., Schunter, F. & Flegel, W.A. (1999) Molecular basis of weak D phenotypes. Blood, 93, 385-393.
76. Wagner, F.F., Frohmajer, A., Ladewig, B., Eicher, N.I., Lonicer, C.B., Müller, T.H., Siegel, M.H. & Flegel, W.A. (2000) Weak D alleles express distinct phenotypes. Blood, 95, 2699-2708.
77. Wagner, F.F., Frohmajer, A. & Flegel, W.A. (2001) RHD positive haplotypes in D negative Europeans. BMC Genetics, 2, 10.
78. Wagner, F.F., Moulds, J.M., Tounkara, A., Kouriba, B. & Flegel, W.A. (2003) RHD allele distribution in Africans of Mali. BMC Genetics, 4, 14.
79. Wagner, T., Körmöczi, G.F., Buchta, C., Vadon, M., Lanzer, G., Mayr, W.R. & Legler, T.J. (2005) Anti-D immunization by DEL red blood cells. Transfusion, 45, 520-526.
80. Wallace, M., Lomas-Francis, C., Beckers, E., Bruce, M., Campbell, G., Chatfield, S., Nagao, N., Okubo, Y., Opalka, A., Overbeeke, M., Scott, M. & Voak, D. (1997) DBT: a partial D phenotype associated with the low-incidence antigen Rh32. Transfusion Medicine, 7, 233-238.
81. Westhoff, C.M., Vege, S., Halter-Hipsky, C., Whorley, T., Hue-Roye, K., Lomas-Francis, C. & Reid, M.E. (2010) DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications. Transfusion, 50, 1303-1311.
82. u-positive women: a cause of hemolytic disease of the newborn. American Journal of Obstetrics & Gynecology, 145, 1069-1075.
83. D. Transfusion, 2, 230-233.
84. Wikman, A.T., Tiblad, E., Karlsson, A., Olsson, M.L., Westgren, M. & Reilly, M. (2012) Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstetrics & Gynecology, 120, 227-234.
85. Yazdanbakhsh, K., Ware, R.E. & Noizat-Pirenne, F. (2012) Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood, 120, 528-537.
86. Yazer, M.H. & Triulzi, D.J. (2007) Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion, 47, 2197-2201.
87. Yu, X., Wagner, F.F., Witter, B. & Flegel, W.A. (2006) Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion, 46, 1343-1351.